BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 17982458)

  • 1. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells.
    Pandiyan P; Zheng L; Ishihara S; Reed J; Lenardo MJ
    Nat Immunol; 2007 Dec; 8(12):1353-62. PubMed ID: 17982458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
    Yurchenko E; Levings MK; Piccirillo CA
    Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of EBI3 and Foxp3 in CD4+CD25+ regulatory T cells in murine experimental allergic rhinitis.
    Ouyang Y; Nakao A; Fan E; Li Y; Zhao L; Zhang W; Han D; Zhang L
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):313-20. PubMed ID: 21986066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
    Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
    Nie CQ; Bernard NJ; Schofield L; Hansen DS
    Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
    Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
    J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis.
    Wu YE; Peng WG; Cai YM; Zheng GZ; Zheng GL; Lin JH; Zhang SW; Li K
    Int J Infect Dis; 2010 Sep; 14(9):e815-22. PubMed ID: 20655262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) CD25(+) FoxP3(+) regulatory T cells suppress cytotoxicity of CD8(+) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level.
    Göbel K; Bittner S; Melzer N; Pankratz S; Dreykluft A; Schuhmann MK; Meuth SG; Wiendl H
    J Neuroinflammation; 2012 Feb; 9():41. PubMed ID: 22373353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation.
    Mahic M; Yaqub S; Bryn T; Henjum K; Eide DM; Torgersen KM; Aandahl EM; Taskén K
    J Leukoc Biol; 2008 May; 83(5):1111-7. PubMed ID: 18270250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.
    Schneider MA; Meingassner JG; Lipp M; Moore HD; Rot A
    J Exp Med; 2007 Apr; 204(4):735-45. PubMed ID: 17371928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties.
    Merlo A; Tagliabue E; Mènard S; Balsari A
    Immunol Lett; 2008 Apr; 117(1):106-13. PubMed ID: 18295349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.